Piramal Pharma announces that Mr. Subramanian Ramadorai‘s tenure as an Independent Director concludes on February 8, 2026, after serving for five consecutive years. Mr. Ramadorai has decided to retire from the Board to focus on personal priorities and will not seek reappointment. The Board has expressed its gratitude for his valuable contributions during his tenure.
Independent Director’s Departure
Mr. Subramanian Ramadorai will cease to be an Independent Director of Piramal Pharma, effective February 9, 2026. This follows the completion of his 5-year term. He also served as Chairman/Member of various Board Committees.
Reason for Departure
Mr. Ramadorai expressed his desire to retire from the Board to pursue personal interests, and therefore, did not offer himself for consideration for another term.
Board’s Acknowledgment
The Board of Directors acknowledges and appreciates the valuable insights and guidance provided by Mr. Ramadorai throughout his service. The Board has also re-constituted the Committees in accordance with regulatory requirements.
Source: BSE
